pseudomonas vaccine

pseudomonas vaccine

An obsolete vaccine prepared from Pseudomonas aeruginosa intended to protect a subject against future Pseudomonas infections and increase survival rates in burn victims (who suffer higher rates of Pseudomonas infection).
References in periodicals archive ?
Next steps defined for Pseudomonas vaccine candidate: Agreement with Novartis to advance investigational Pseudomonas vaccine into confirmatory clinical efficacy trial in ventilated ICU patients
The UBS experts see the development of the new pseudomonas vaccine in partnership with Swiss drug maker Novartis (VTX:NOVN) as a propeller for Intercell's financial figures.
The company's pipeline includes a Travelers' Diarrhea Vaccine Patch (Phase III in preparation), a Pseudomonas vaccine candidate (Phase II), a Vaccine Enhancement Patch to prevent Pandemic Influenza in combination with an injected vaccine (Phase II), a vaccine program for S.
We hope to get the pseudomonas vaccine here soon - the initial trials seem promising.
the encouraging Phase II data in the Pseudomonas vaccine program and the imminent clinical entry of the Company's novel investigational C.
Next important data points expected from Phase II studies for investigational single-application Pandemic Influenza vaccine system in Q2 and for Pseudomonas vaccine in Q3 2010.
The Company's pipeline includes a Travelers' Diarrhea Vaccine Patch (Phase II concluded), a Pseudomonas vaccine candidate (Phase II), a Vaccine Enhancement Patch to prevent Pandemic Influenza in combination with an injected vaccine (Phase II), a vaccine program for S.
The Company's pipeline includes a Travelers' Diarrhea Vaccine Patch (Phase II), a Pseudomonas vaccine candidate (Phase II), a Vaccine Enhancement Patch with infected Pandemic Influenza vaccines (one shot plus patch, Phase I), a Phase II vaccine program for S.
The company's broad development pipeline includes a Travelers' Diarrhea vaccine (patch) in Phase II (start of Phase III expected in 2009), a Pseudomonas vaccine in Phase II, as well as a pandemic Influenza Vaccine Enhancement patch, a partnered S.
aureus vaccine in Phase II, a therapeutic vaccine against Hepatitis C in Phase II, a Pseudomonas vaccine in Phase II, a partnered Tuberculosis vaccine (Phase